Medinice S.A. (WSE:ICE)
Poland flag Poland · Delayed Price · Currency is PLN
70.30
-3.50 (-4.74%)
Aug 14, 2026, 5:01 PM CET

Medinice Company Description

Medinice S.A., a medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery.

The company offers PacePress, a medical device to reduce the risk of complications following the implantation of cardiac electrotherapeutic devices, such as pacemakers or implantable cardioverter-defibrillators; CoolCryo, a cardiac cryoablation technology that uses liquid nitrogen as the cooling medium; and AtriClamp, a clip designed to close the left atrial appendage to minimize the risk of stroke in patients with atrial fibrillation.

It also provides MiniMax, an ablation-mapping catheter used for detecting intracardiac electrophysiological signals, creating a 3D map of the heart, and performing intracardiac irrigated RF ablation to treat arrhythmias caused by abnormalities in the heart’s conduction system; and EP Bioptom, an electrode for endomyocardial biopsy using 3D mapping enabling simultaneous biopsy and creation of a three-dimensional heart map.

The company was founded in 2012 and is headquartered in Warsaw, Poland.

Medinice S.A.
CountryPoland
Founded2012
IndustryMedical Devices
SectorHealthcare
Employees10
CEOSanjeev Choudhary

Contact Details

Address:
Hankiewicza St. 2
Warsaw, 02-103
Poland
Phone48 725 50 00 51
Websitemedinice.pl

Stock Details

Ticker SymbolICE
ExchangeWarsaw Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyPLN
ISIN NumberPLMDNCE00016
SIC Code3845

Key Executives

NamePosition
Sanjeev ChoudharyPresident of the Management Board and Chief Executive Officer
Paul SobkiewiczChief Operating Officer
Piotr LozinskiChief Financial Officer
Grzegorz WroblewskiChief Technology Officer